ACE2 and COVID-19: It has also been proposed that the COVID-19 virus may have direct access to renal parenchyma via the receptor activity of angiotensin-converting enzyme 2 [4], although evidence for this has been inconsistent and does not allow for unequivocal confirmation of the hypothesis [5].